Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tea tree oil gel versus potassium permanganate for tungiasis in children
PACTR202003651095100Phase 2Not yet recruiting
- Sponsor
- University of Canberra
- Start
- Jun 2020
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Tea tree oil and potassium permanganate in tungiasis (2 arms), sponsored by University of Canberra. Primary endpoint: Proportion of non-viable embedded sand fleas. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
Tea tree oilpotassium permanganate
03
Conditions
tungiasis
Beyond the preview
Go deeper on PACTR202003651095100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202003651095100.